Prostaglandin E2 Production by Endotoxin-Stimulated Alveolar Macrophages Is Regulated by Phospholipase C Pathways

Journal of Trauma - Injury, Infection and Critical Care

Volumn 40, Issue 4, 1996, Pages 557-562

  Lo, Chong Jeh ^a,c   Cryer, H Gill ^a   Maier, Ronald V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PHOSPHOLIPASE C; PROSTAGLANDIN E2; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BACTERIUM LIPOPOLYSACCHARIDE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL; ARTICLE; BIOSYNTHESIS; LUNG ALVEOLUS MACROPHAGE; MALE; METABOLISM; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PHYSIOLOGY; RABBIT; SIGNAL TRANSDUCTION; ANIMAL CELL; CALCIUM CELL LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; HOST RESISTANCE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ANIMALS; DINOPROSTONE; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MULTIPLE ORGAN FAILURE; PHOSPHOLIPASE C; RABBITS; SIGNAL TRANSDUCTION;

EID: 0029942563     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199604000-00006     Document Type: Article

References (41)

1. Faist E, Baue AE, Dittmer H, et al: Multiple organ failure in polytrauma patients. J Trauma 23:775, 1983
2. Bone RC: Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452, 1992
3. Meakins JL: Etiology of multiple organ failure. J Trauma 30:S165, 1990
4. Parrillo JE: Management of septic shock: present and future. Ann Intern Med 115:491, 1991
5. Carrico CJ, Meakins JL, Marshall JC, et al: Multiple-organ-failure syndrome. Arch Surg 121:196, 1985
6. Nathan CF: Secretory products of macrophages. J Clin Invest 79:319, 1987
7. Feuerstein G, Hallenbeck JM: Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol 27:301, 1987
8. Jacobs ER, Soulsby ME, Bone RC, et al: Ibuprofen in canine endotoxin shock. J Clin Invest 70:536, 1982
9. Demling RH, Smith M, Gunther R, et al: Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol 240:H348, 1981
10. Halushka PV, Wise WC, Cook JA: Protective effects of aspirin in endotoxic shock. J Pharmacol Exp Ther 218:464, 1981
11. Fletcher JR, Collins JN, Graves ED, et al: Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann Surg 217:668, 1993
12. Wahl LM, Olsen CE, Sandberg AL, et al: Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci USA 74:4955, 1977
13. 2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway. Surgery 114:314, 1993
14. 2. Biochem Biophys Res Commun 137:404, 1986
15. Ayala A, Lehman DL, Herdon CD, et al: Mechanism of enhanced susceptibility to sepsis following hemorrhage. Arch Surg 129:1172, 1994
16. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361:315, 1993
17. Divecha N: Phospholipid signaling. Cell 80:269, 1995
18. Bansal VS, Majerus PW: Phosphatidylinositol-derived precursors and signals. Annu Rev Cell Biol 6:41, 1990
19. Majerus PW: Inositol phosphate biochemistry. Annu Rev Biochem 61:225, 1992
20. Brain JE, Frank R: Alveolar macrophage adhesion: wash electrolyte composition and free cell yield. J Appl Physiol 34:75, 1973
21. Stefanova I, Horejsi V, Ansotegui IJ, et al: GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016, 1991
22. Faist E, Mewes A, Strasser T, et al: Alteration of monocyte function following major injury. Arch Surg 123:287, 1988
23. 2 production in severely injured patients. Arch Surg 123:293, 1988
24. Ninnemann JL, Stockland AE: Participation of prostaglandin E in immunosuppression following thermal injury. J Trauma 24:201, 1984
25. Krebs EG: Role of the cyclic AMP-dependent protein kinase in signal transduction. JAMA 262:1815, 1989
26. Tobias PS, Soldau K, Kline L, et al: Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J Immunol 150:3011, 1993
27. Ulevitch RJ, Wolfson N, Virca GD, et al: Macrophages regulate the host response to bacterial lipopolysaccharides. Prog Clin Biol Res 299:193, 1989
28. Martin TR, Mathison JC, Tobias PS, et al: Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. J Clin Invest 90:2209, 1992
29. Lee J, Kravchenko V, Kirkland TN, et al: Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 90:9930, 1993
30. Han J, Lee J-D, Tobias PS, et al: Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem 268:25009, 1993
31. Thastrup O, Dawson AP, Scharff O, et al: Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions 27:17, 1989
32. Irvine RF: How is the level of free arachidonic acid controlled in mammalian cells? Biochem J 204:3, 1982
33. 2 in human volunteers challenged with intravenous endotoxin. Inflammation 16:561, 1992
34. 2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci. 50:807, 1992
35. 2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Inflammation 15:355, 1991
36. 2 is phosphorylated and activated by MAP kinase. Cell 72:269, 1993
37. 2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043, 1991
38. 2. J Biol Chem 266:14850, 1991
39. Mayer A, Glaser KB, Jacobs RS: Regulation of eicosanoid biosynthesis in vitro and in vivo by the marine natural product manoalide: a potent inactivator of venom phospholipases, J Pharmacol Exp Ther 244:871, 1988
40. 2. Biochemistry 32:5935, 1993
41. Struhar D, Kivity S, Topilsky M: Quinacrine inhibits oxygen radicals release from human alveolar macrophages. Int J Immunopharmacol 14:275, 1992